What's scarier: dying with regrets, failing your sales pitch, or losing your research funding?
In this week's episode, Chris and Melissa talk regrets, sales secrets, and grant drama.
The 5 Most Common Deathbed Regrets: https://www.msn.com/en-us/lifestyle/lifestyle-buzz/the-five-most-common-deathbed-regrets-as-told-to-instagram-star-hospice-nurses/ar-AA1GnE5y?ocid=hpmsn&cvid=4763b931e2b54de0b75762d2e90a84bf&ei=20
10 Laws of Selling Health Tech to Health Systems: https://www.linkedin.com/posts/joshuapliu_10-laws-for-selling-health-tech-activity-7338309534106439680-YSBu?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAG4dk8B7FNW_1ag1B9259roypJ8QSpelk0
NIH Walks Back DEI Ban: https://www.statnews.com/2025/06/09/nih-rescinds-dei-ban-israel-boycotts-grants-says-awaiting-further-government-wide-guidance/
Hosts:
Chris Hemphill
Chris’s 17 years in healthcare technology have spanned sales, operations, data science IC, and AI leadership. Chris couples this with a focus on health equity and serves as the NYU McSilver Institute for Poverty Policy Research Fellow for Healthcare AI. Chris’s currently leads Modular Feedback, which focuses on helping healthcare innovators find and build thoughtful AI use cases: https://modularfeedback.com
Melissa Reilly
Melissa spent the last 20 years leading innovations at major payers: UnitedHealth Group(Optum Ventures), Aetna, and Evernorth/Cigna. She’s helped drive and commercialize multiple startups in AI & consumer testing, and she is now driving product and commercialization for healthcare innovators full-time. She brings industry expertise as well as a background in law, negotiation, & real estate. Her company’s name is STLTH.